You are here
Clinical Trials: Stroke and Related
Discuss
Each Clinical Trial will open in a new browser window or tab.
Condition: Cerebral Infarction
Interventions: Biological: Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#); Drug: Aspirin Tablet
Sponsor: Sclnow Biotechnology Co., Ltd.
Not yet recruiting - verified April 2017
Interventions: Biological: Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#); Drug: Aspirin Tablet
Sponsor: Sclnow Biotechnology Co., Ltd.
Not yet recruiting - verified April 2017
Condition: Cerebral Infarction
Interventions: Biological: Allogeneic umbilical cord mesenchymal stem cell; Drug: Aspirin Enteric-coated Tablets & Atorvastatin Calcium
Sponsor: Sclnow Biotechnology Co., Ltd.
Not yet recruiting - verified May 2017
Interventions: Biological: Allogeneic umbilical cord mesenchymal stem cell; Drug: Aspirin Enteric-coated Tablets & Atorvastatin Calcium
Sponsor: Sclnow Biotechnology Co., Ltd.
Not yet recruiting - verified May 2017
Condition: Hypoxic-Ischemic Encephalopathy
Intervention: Procedure: Umbilical Cord Milking
Sponsor: Jubilee Mission Medical College and Research Institute
Not yet recruiting - verified April 2017
Intervention: Procedure: Umbilical Cord Milking
Sponsor: Jubilee Mission Medical College and Research Institute
Not yet recruiting - verified April 2017
Condition: Neonatal Hypoxic-ischaemic Encephalopathy
Intervention: Drug: autologous cord blood stem cell
Sponsor: Assistance Publique Hopitaux De Marseille
Not yet recruiting - verified August 2016
Intervention: Drug: autologous cord blood stem cell
Sponsor: Assistance Publique Hopitaux De Marseille
Not yet recruiting - verified August 2016
Condition: Stroke
Interventions: Other: Adipose Derived Stem Cells; Other: Vehicle media
Sponsors: University Hospital, Grenoble; European Commission H2020 program; Univ Grenoble Alpes, France; Servicio Madrileño de Salud, Madrid, Spain; Fakultni Nemocnice U Sv. Anny v Brne, Brno, Czech Republic; Servicio Andaluz de Salud, Spain; University of Glasgow; University of Eastern Finland; Etablissement Français du Sang; University of Tampere; Histocell SL, Spain; Medfiles CRO, Finland; Institut National de la Santé Et de la Recherche Médicale, France; Hospices Civils de Lyon; Association groupe ESSEC, France; NOVADISCOVERY SAS, France; FINOVATIS, France; CHU Besancon, France; Assistance Publique - Hôpitaux de Paris; CHU Toulouse, France; CHU Bordeaux, France; CHU Cote de Nacre, Caen, France; Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León; Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Servicio de Salud de Castilla La Mancha, Albacete, Spain; Servizo Galego de Saude, Santiago de Compostela, Spain; Pirkanmaa Hospital District, Tampere, Finland; Hospital Vall d'Hebron; Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Recruiting - verified July 2016
Interventions: Other: Adipose Derived Stem Cells; Other: Vehicle media
Sponsors: University Hospital, Grenoble; European Commission H2020 program; Univ Grenoble Alpes, France; Servicio Madrileño de Salud, Madrid, Spain; Fakultni Nemocnice U Sv. Anny v Brne, Brno, Czech Republic; Servicio Andaluz de Salud, Spain; University of Glasgow; University of Eastern Finland; Etablissement Français du Sang; University of Tampere; Histocell SL, Spain; Medfiles CRO, Finland; Institut National de la Santé Et de la Recherche Médicale, France; Hospices Civils de Lyon; Association groupe ESSEC, France; NOVADISCOVERY SAS, France; FINOVATIS, France; CHU Besancon, France; Assistance Publique - Hôpitaux de Paris; CHU Toulouse, France; CHU Bordeaux, France; CHU Cote de Nacre, Caen, France; Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León; Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Servicio de Salud de Castilla La Mancha, Albacete, Spain; Servizo Galego de Saude, Santiago de Compostela, Spain; Pirkanmaa Hospital District, Tampere, Finland; Hospital Vall d'Hebron; Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Recruiting - verified July 2016
Condition: Stroke
Intervention: Drug: ADSCs
Sponsor: Gwo Xi Stem Cell Applied Technology Co., Ltd.
Not yet recruiting - verified June 2016
Intervention: Drug: ADSCs
Sponsor: Gwo Xi Stem Cell Applied Technology Co., Ltd.
Not yet recruiting - verified June 2016
Condition: Stroke
Interventions: Behavioral: Mirror Box Therapy; Behavioral: Sham Mirror Box Therapy
Sponsors: Columbia University; Helen Hayes Hospital
Not yet recruiting - verified May 2016
Interventions: Behavioral: Mirror Box Therapy; Behavioral: Sham Mirror Box Therapy
Sponsors: Columbia University; Helen Hayes Hospital
Not yet recruiting - verified May 2016
Condition: Stroke
Intervention: Drug: Intravenous stem cell transplantation
Sponsors: Southern Medical University, China; Second Affiliated Hospital of Guangzhou Medical University
Recruiting - verified November 2015
Intervention: Drug: Intravenous stem cell transplantation
Sponsors: Southern Medical University, China; Second Affiliated Hospital of Guangzhou Medical University
Recruiting - verified November 2015
Condition: Stroke
Intervention: Genetic: Intravenous stem cell transplantation
Sponsors: Southern Medical University, China; Second Affiliated Hospital of Guangzhou Medical University
Recruiting - verified September 2015
Intervention: Genetic: Intravenous stem cell transplantation
Sponsors: Southern Medical University, China; Second Affiliated Hospital of Guangzhou Medical University
Recruiting - verified September 2015
Condition: Stroke
Intervention: Biological: Human umbilical cord mesenchymal stem cells
Sponsor: Affiliated Hospital to Academy of Military Medical Sciences
Not yet recruiting - verified July 2015
Intervention: Biological: Human umbilical cord mesenchymal stem cells
Sponsor: Affiliated Hospital to Academy of Military Medical Sciences
Not yet recruiting - verified July 2015
